![No Picture](https://businessnewsthisweek.com/wp-content/themes/mh-magazine/images/placeholder-medium.png)
Glenmark commences 1000 patients Post Marketing Surveillance study with COVID-19 who are administered FabiFlu®
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in 1000 patients […]